Other
Sale of investments
Medtronic Sale of investments increased by 5.3% to $2.00B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.3%, from $1.90B to $2.00B.
Analysis
StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2018
Last reportedQ3 2026Feb 24, 2026
How to read this metric
High proceeds may indicate active portfolio rebalancing or a strategy to lock in investment gains.
Detailed definition
Represents the cash inflows from the sale of debt securities classified as available-for-sale. This reflects the company...
Peer comparison
Standard metric for insurance companies with large investment portfolios.
Metric ID:
other_proceeds_from_sale_of_available_for_sale_securities_debtHistorical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.27B | $2.30B | $2.48B | $1.86B | $1.72B | $1.78B | $1.75B | $1.57B | $1.79B | $2.20B | $2.10B | $1.90B | $2.00B | $1.90B | $2.00B |
| QoQ Change | — | +1.2% | +7.9% | -24.9% | -7.6% | +3.1% | -1.7% | -10.0% | +14.0% | +22.6% | -4.5% | -9.5% | +5.3% | -5.0% | +5.3% |
| YoY Change | — | — | — | -18.0% | -25.1% | -28.4% | -6.3% | -8.7% | +1.0% | +25.9% | +33.5% | +5.9% | -9.1% | -9.5% | +5.3% |
Range$1.57B – $2.48B
CAGR-3.6%
Avg YoY Growth-2.8%
Median YoY Growth-7.5%
Sale of investments at Other Companies
Frequently Asked Questions
- What is Medtronic's sale of investments?
- Medtronic (MDT) reported sale of investments of $2.00B in Q4 2025.
- How has Medtronic's sale of investments changed year-over-year?
- Medtronic's sale of investments increased by 5.3% year-over-year, from $1.90B to $2.00B.
- What does sale of investments mean?
- Cash received from selling debt investments held in the portfolio.